October 19, 2020
A new study at the intersection of genetic sequencing technology and human brain evolution reveals the workings of a repeat expansion linked to ALS risk, for the first time.
Categories: Research, ALS, ADRC News
March 07, 2017
C9ORF72-linked FTD and ALS join the ranks of Huntington's disease and spinal muscular atrophy as targets of groundbreaking antisense oligonucleotide clinical drug trials. Clinicians deal with a genetic testing conundrum.
Categories: Research, Clinical Care, Precision Medicine, FTD Disorders, ALS, ADRC News